Other Services

This Service

A database built with INDRA combining content from numerous readers and databases. This page allows you to curate the loaded statements. For more information please see the manual.

This Project

INDRA is developed by indralabs, a part of the Harvard Medical School Laboratory of Systems Pharmacology.

This project, indra_db, is also developed by the indralab team. For more information on how we procure our sources, you can go here. This work was funded by ARO grant W911NF‐15‐1‐0544 under the DARPA Communicating with Computers program.

IndraLab

Statements

FBXL3 inhibits mutated ATXN3. 1 / 1

| 1

➶

reach

"We overexpressed FBXL3 in SCA3 NPCs and confirmed that high levels of FBXL3 reduce endogenous levels of both wild-type and mutant ATXN3 proteins to 58% and 64%, respectively, of control levels (XREF_FIG)."

31783119

Our Sources:

INDRA allows us to combine the results from a multitude of sources. In particular, the INDRA Database draws on the following...